Growth Metrics

Integra Lifesciences Holdings (IART) Change in Cash (2016 - 2026)

Integra Lifesciences Holdings' Change in Cash history spans 17 years, with the latest figure at $2.9 million for Q4 2025.

  • On a quarterly basis, Change in Cash fell 90.83% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$11.3 million, a 62.28% increase, with the full-year FY2025 number at -$11.3 million, up 62.28% from a year prior.
  • Change in Cash hit $2.9 million in Q4 2025 for Integra Lifesciences Holdings, down from $14.3 million in the prior quarter.
  • Over the last five years, Change in Cash for IART hit a ceiling of $315.5 million in Q1 2024 and a floor of -$376.7 million in Q2 2024.
  • Historically, Change in Cash has averaged -$11.8 million across 5 years, with a median of $873000.0 in 2023.
  • Biggest five-year swings in Change in Cash: plummeted 20739.45% in 2024 and later soared 18165.82% in 2025.
  • Tracing IART's Change in Cash over 5 years: stood at $43.2 million in 2021, then tumbled by 227.9% to -$55.3 million in 2022, then skyrocketed by 104.83% to $2.7 million in 2023, then surged by 1069.21% to $31.2 million in 2024, then tumbled by 90.83% to $2.9 million in 2025.
  • Business Quant data shows Change in Cash for IART at $2.9 million in Q4 2025, $14.3 million in Q3 2025, and -$21.2 million in Q2 2025.